Peptide inhibitors of human HMG-CoA reductase as potential hypocholesterolemia agents

被引:20
|
作者
Lin, Shih-Hung [1 ,2 ]
Chang, Ding-Kwo [3 ]
Chou, Mei-Ju [3 ]
Huang, Kao-Jean [1 ,2 ]
Shiuan, David [1 ,2 ]
机构
[1] Natl Dong Hwa Univ, Dept Life Sci, Hualien 974, Taiwan
[2] Natl Dong Hwa Univ, Inst Biotechnol, Hualien 974, Taiwan
[3] Acad Sinica, Inst Chem, Taipei 112, Taiwan
关键词
HMG-CoA reductase; Phage display; Molecule docking; PROTEIN; LIBRARIES; MECHANISM;
D O I
10.1016/j.bbrc.2014.11.042
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hypercholesterolemia may lead to obesity and cardiovascular diseases. To prevent hypercholesterolemia, many drugs have been developed while searching for better drugs to treat hypercholesterolemia has never been ended. Other than small molecule drugs, peptide drugs are gaining more visibilities in many therapeutic areas. In the present study, we employed phage-display techniques to screen peptide inhibitors against human HMG-CoA reductase. The results indicate that the tetrapeptide PMAS inhibits hHMGR effectively (IC50=68 mu M), could be a lead compound to develop hypocholesterolemic agents. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:104 / 109
页数:6
相关论文
共 50 条